Ige Mediated Reactions
Ige Mediated Reactions - Related Videos
10:22
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
0 Views •
Cited by 14 •
2011
Basophil activation test is a potent tool for the detection of IgE-dependent allergies in vitro. Here, an optimized protocol for basophil activation test is used to investigate drug hypersensitivity. A method for the efficient production of covalent drug-protein conjugates and their physicochemical characterization is described.
09:40
Detection of True IgE-expressing Mouse B Lineage Cells
0 Views •
Cited by 3 •
2014
In vitro analysis of class switch recombination in mice is challenging due to cytophilic IgE molecules bound to Fc receptors on the surface of B cells. We describe a method for IgE detection using trypsin-mediated cleavage of surface-bound IgE prior to fixation and permeabilization for cytoplasmic fluorescence staining.
02:06
Allergic Reactions
0 Views •
2019
Overview We speak of an allergy when the immune system triggers a response against a benign foreign structure, like food, pollen or pet dander. These elicitors are called allergens. If the immune system of a hypersensitive individual was primed against a specific allergen, it will trigger allergic symptoms during every subsequent encounter of the allergen. Symptoms can be mild, such as hay fever, to severe, such as potentially fatal anaphylactic shock. Sensitization Is the First Step of an...
05:39
Humanized Mediator Enzyme Release Assay: An Immunochemical Method to Screen Allergic Potential of Test Antigen by Monitoring Basophil Degranulation Response In Vitro
0 Views •
2025
In this video, we describe an in vitro method to evaluate the allergic potential of an antigen to induce basophil degranulation. β-hexosaminidase is used as an index of chemical mediator release, and the enzyme activity of β-hexosaminidase is measured using a fluorogenic substrate.
01:25
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
0 Views •
2024
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed. Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
FAQs
After sensitization, IgE antibodies remain bound to high-affinity FcεRI receptors on mast cells and basophils. When the same allergen is encountered again, it binds neighboring IgE molecules and cross-links them. This receptor clustering activates the cells and prompts degranulation, providing the immediate cellular trigger for mediator release and allergic inflammation.
The released mediators act on different tissues and physiological processes. Histamine and related substances can alter blood vessels, producing swelling and other vascular changes, while effects in the airways can cause bronchoconstriction. Together, these activities help explain the rapid combination of itching, tissue swelling, and breathing-related symptoms seen in some IgE-mediated reactions.
The initial mediator release accounts for rapid symptoms, but inflammation may continue through a later phase. This means the clinical effects are not necessarily limited to the first response after allergen exposure. Recognizing both phases helps clinicians interpret the progression of allergic disease and understand why IgE-mediated inflammation can have continuing consequences.
Allergy testing can help identify the specific allergens recognized by a patient's IgE antibodies. That information supports clinical diagnosis by connecting an immune response with a suspected trigger. Because the reaction is allergen-specific, testing is useful for distinguishing relevant sensitization patterns and for guiding further evaluation of allergic disease.
Anaphylaxis can involve rapid, widespread effects from mediator release, including vascular changes, swelling, and bronchoconstriction. Understanding the sequence from allergen recognition to mast-cell and basophil activation provides a mechanistic basis for recognizing the seriousness of the reaction. This knowledge supports clinical diagnosis and the selection of appropriate emergency treatment.
The pathway identifies several clinically relevant points for intervention, including allergen recognition, IgE binding, FcεRI receptor signaling, cellular degranulation, and mediator activity. Therapies designed around these components can target specific stages rather than treating allergic inflammation as an undifferentiated process. This mechanistic approach supports research into more focused treatments for allergic disease.